Search

everythingexperts & clinicslearnfaqsresearchcommunity

for

Search:↓

This study suggests that integrating barber care with medical treatment improves scalp condition and psychological well-being in early stages of hair loss, by enhancing medication efficacy and reducing stress.

This chapter reviews the complex relationship between PCOS and sexual dysfunction, highlighting its fundamental role as a biopsychosocial manifestation rather than a secondary complication, and calls for comprehensive, patient-centered care; it reports no new clinical results.

In this study, analysis of electronic health records suggested that patients taking semaglutide were significantly less likely to experience suicidal ideation compared to those on non-GLP-1 obesity or diabetes medications.

In this study, researchers found that Derinat, a TRPCs inhibitor, reduced oxidative stress and prolonged the anagen phase of hair growth in mice, supporting its potential as a therapy for androgenetic alopecia by improving clinical outcomes and enhancing quality of life for those affected.

A thorough initial check-up is essential before sperm banking to ensure the best chance of preserving good quality sperm.

This article reviews how to properly take a dermatological history and conduct physical examinations for skin rashes and malignancies, discussing commonly used diagnostic tools and the Dermatology Life Quality Index system.

This study established a new in vitro culture system that supports the growth and dynamic self-organization of hair follicle stem cells and their progeny, promoting a stable population equilibrium.

This case report describes two instances of rare linear alopecia on the occipital scalp, associated histologically with lupus erythematosus profundus, despite resembling alopecia areata clinically.

New cosmetic treatments for acne, hair loss, cellulite, wrinkles, and skin resurfacing are effective.

This review found that recent innovations, such as topical medications, lasers, and microneedling, have shown significant reductions in androgenetic alopecia indicators, but more research is needed to refine treatments.

This study identified ten potential therapeutic targets and biomarkers for androgenic alopecia, with SOD1 and KL as particularly promising candidates for future therapies.

This study reported that among patients aged 19 to 60 who experienced hair loss after COVID-19, a treatment involving a complex drug and peptide lotion led to hair improvement in 92% of cases, with good tolerability and no reported side effects.

This study found that anti-TNF therapy-induced alopecia exhibits distinct clinical and histopathological features and can mimic psoriatic alopecia and alopecia areata, with some patients improving with topical treatment.

This case report describes a family with autosomal dominant transmission of keratosis follicularis spinulosa decalvans, with observed treatment refractoriness in multiple topical and systemic therapies.

This study found that vitamin supplementation may not significantly improve hair density or diameter in patients with non-scarring alopecia, questioning the utility of laboratory testing for vitamin deficiencies.

Finasteride and dutasteride increase sexual dysfunction reports.

This study suggests that the floral secretions of Brasiliorchis schunkeana may attract Diptera as potential pollinators, but field observations are needed to confirm this pollination syndrome.

This study found that teriflunomide, an oral medication taken once daily, significantly slowed disability progression in patients with relapsing multiple sclerosis, supported by positive results in two Phase III trials and supplemented by various analyses including long-term studies and patient-reported outcomes.

This meta-analysis reported that finasteride 1 mg/day significantly increased hair count in male androgenetic alopecia compared to placebo, but highlighted persistent sexual side effects and associated depression risk.

This analysis found that spironolactone use is not associated with an increased risk of breast cancer recurrence in female survivors.

This analysis explored Ayurveda's approach to addressing hair fall, emphasizing the use of herbs and lifestyle modifications for prevention and regrowth, and critically examined classical Ayurvedic concepts related to causation and treatment of hair loss.

Some medications and supplements can cause serious side effects, including hair loss, heart rhythm problems, liver injury, and other health issues.

This article reviews the endocrine changes in anorexia nervosa and bulimia nervosa, highlighting hypoleptinemia as a potential mediator, but does not present any new clinical results.

Long-term use of a certain medication can worsen erectile function in aged rats by damaging penile muscle cells.

This article discusses fluconazole's pharmacological and physicochemical properties and methods for its analysis, but reports no new clinical results.

The document concludes that various medications and treatments can have significant, sometimes adverse, effects on health outcomes.

This study suggests that polygonum multiflorum may treat androgenic alopecia by mediating the PI3K/Akt pathway to regulate apoptosis, inhibit inflammation and oxidative stress, and induce melanin production.

This study found that collecting hair samples for cortisol analysis is feasible in community-dwelling individuals with longstanding multiple sclerosis, although no significant correlation between hair cortisol levels and perceived chronic stress was observed, highlighting the complexity of stress measurement in this population.

This study found that BEO inhibited cell proliferation and inflammatory mediator release in a human keratinocyte acne model and reduced acne lesion severity in a rabbit model, suggesting its potential as a natural alternative to conventional acne treatments.

A man developed hair loss from testosterone treatment but improved with additional medication.